Novartis opens manufacturing plant in Maharashtra
01 July 2022 | News
The new facility will produce oncology-focused medicines covering both cancer and blood disorders
Sandoz Technical Operations, a Novartis division, has inaugurated its manufacturing plant for medicines and therapies at Kalwe in Mumbai.
The plant, which marks a new chapter for Sandoz, will further strengthen the company’s operations in India to support growing healthcare needs globally. The new facility will manufacture oral cancer medicines for the global market and will play a key role in enabling the delivery of high-quality cancer treatment.
The manufacturing facility is spread across 32000 sqm, and houses state-of-the-art production technology. Additionally, built on a brownfield, effluent treatment units installed at the plant shape a next-gen environmentally sustainable manufacturing atmosphere.
